Non-serious case reports

  • PDF / 153,003 Bytes
  • 1 Pages / 595.245 x 841.846 pts (A4) Page_size
  • 47 Downloads / 201 Views

DOWNLOAD

REPORT


1

Non-serious case reports The table below provides a list of the drugs associated with non-serious adverse events identified in the scientific literature over the last week. Non-serious case reports Drug name(s)

Adverse event(s)

No. of cases

Alendronic acid

Malaise, Signs symptoms and ill defined conditions Delayed hypersensitivity, Lipoatrophy, Tissue disorders Anaemia Granuloma Psoriasis Abnormal laboratory parameters, Pregnancy

3

10 1 1 1

Eye Disorders Alopecia, Secondary hypertension, Skin disorders Blepharoptosis Dermatitis

1 1 1 1

Pain Exanthema, Nausea Gastrointestinal disorders, Headache, Insomnia Polyps Skin disorders Eye Disorders Fatigue, Psychological stress Iron overload Diarrhoea Exanthema Constipation Abnormal laboratory parameters, Eczema, Elevated aminotransferase levels, Otitis externa, Psoriasis, Skin infections Fatigue, Irritability Cheilitis, Dry skin Gastrointestinal disorders Agitation, Anxiety, Basal ganglia disorders, Hypersomnia, Social isolation Hyperglycaemia Constipation Atopic dermatitis Nausea Infusion related reaction Diarrhoea Arthralgia, Exanthema Eye Disorders Exanthema Parkinsonian disorders Dizziness, Headache, Palpitations Elevated aminotransferase levels Pain, Ulcer Nausea, Pruritus Anger, Behavioural symptoms, Depression, Fatigue, Hot flashes, Muscle pain Nasopharyngitis Hypohidrosis, Somnolence

1 2 2 1 1 1 3 3 1 1 1 9

Aluminium, Hib DTaP hepatitis B poliovirus vaccine, Pneumococcal vaccine conjugate Anagrelide Anthrax vaccine Atezolizumab Azathioprine, Insulin, Methylprednisolone, Prednisone, Progesterone, Tacrolimus Bevacizumab Bevacizumab, Erlotinib, Pemetrexed Botulinum Toxin A Budesonide/formoterol, Fluticasone propionate, Hydrocortisone Cadi 05 Desmopressin Dexamethasone Dexlansoprazole Diclofenac, Fluorouracil, Imiquimod Dimeticone Enzalutamide Ferric citrate Fosfomycin Gemcitabine Imipramine Infliximab, Ustekinumab, Vedolizumab

Interferon gamma 1b Isotretinoin Methotrexate Methylphenidate, Mirtazapine, Pramipexole, Risperidone Methylprednisolone, Prednisolone Morphine Nafcillin Naltrexone Natalizumab Oseltamivir Pembrolizumab Pentosan polysulfate Phenytoin Risperidone Rivoceranib, Toripalimab Sirolimus Sodium thiosulfate Tacrolimus Tamoxifen Teneligliptin Zonisamide

Non-serious case reports. Reactions Weekly 16 Sep 2020

0114-9954/20/1822-0001/$14.95 Adis © 2020 Springer Nature Switzerland AG. All rights reserved

1

1 1 2 1 1 1 1 1 1 2 1 7 1 1 1 1 1 3 1 1 3

803503313

Reactions 19 Sep 2020 No. 1822